Unveiling Novel Urease Inhibitors for Helicobacter pylori: A Multi-Methodological Approach from Virtual Screening and ADME to Molecular Dynamics Simulations

Vista sencilla de ítem
dc.contributor.authorValenzuela-Hormazabal, Paulina
dc.contributor.authorSepúlveda, Romina V.
dc.contributor.authorAlegría-Arcos, Melissa
dc.contributor.authorValdés-Muñoz, Elizabeth
dc.contributor.authorRojas-Pérez, Víctor
dc.contributor.authorGonzález-Bonet, Ileana
dc.contributor.authorSuardíaz, Reynier
dc.contributor.authorGalarza, Christian
dc.contributor.authorMorales, Natalia
dc.contributor.authorLeddermann, Verónica
dc.contributor.authorCastro, Ricardo I.
dc.contributor.authorBenso, Bruna
dc.date.accessioned2024-04-12T14:31:19Z
dc.date.available2024-04-12T14:31:19Z
dc.date.issued2024-02-04
dc.descriptionIndexación: Scopus.
dc.description.abstractHelicobacter pylori (Hp) infections pose a global health challenge demanding innovative therapeutic strategies by which to eradicate them. Urease, a key Hp virulence factor hydrolyzes urea, facilitating bacterial survival in the acidic gastric environment. In this study, a multi-methodological approach combining pharmacophore- and structure-based virtual screening, molecular dynamics simulations, and MM-GBSA calculations was employed to identify novel inhibitors for Hp urease (HpU). A refined dataset of 8,271,505 small molecules from the ZINC15 database underwent pharmacokinetic and physicochemical filtering, resulting in 16% of compounds for pharmacophore-based virtual screening. Molecular docking simulations were performed in successive stages, utilizing HTVS, SP, and XP algorithms. Subsequent energetic re-scoring with MM-GBSA identified promising candidates interacting with distinct urease variants. Lys219, a residue critical for urea catalysis at the urease binding site, can manifest in two forms, neutral (LYN) or carbamylated (KCX). Notably, the evaluated molecules demonstrated different interaction and energetic patterns in both protein variants. Further evaluation through ADMET predictions highlighted compounds with favorable pharmacological profiles, leading to the identification of 15 candidates. Molecular dynamics simulations revealed comparable structural stability to the control DJM, with candidates 5, 8 and 12 (CA5, CA8, and CA12, respectively) exhibiting the lowest binding free energies. These inhibitors suggest a chelating capacity that is crucial for urease inhibition. The analysis underscores the potential of CA5, CA8, and CA12 as novel HpU inhibitors. Finally, we compare our candidates with the chemical space of urease inhibitors finding physicochemical similarities with potent agents such as thiourea.
dc.identifier.citationInternational Journal of Molecular Sciences Open AccessVolume 25, Issue 4 February 2024 Article number 1968
dc.identifier.doi10.3390/ijms25041968
dc.identifier.issn16616596
dc.identifier.urihttps://repositorio.unab.cl/handle/ria/55892
dc.language.isoen
dc.publisherMDPI
dc.rights.licenseCC BY 4.0 DEED Attribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectcomputer-aided drug design
dc.subjectHelicobacter pylori
dc.subjectmolecular dynamics simulations
dc.subjectpharmacophore-based virtual screening
dc.subjectstructure-based virtual screening
dc.subjecturease
dc.titleUnveiling Novel Urease Inhibitors for Helicobacter pylori: A Multi-Methodological Approach from Virtual Screening and ADME to Molecular Dynamics Simulations
dc.typeArtículo
Archivos
Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Valenzuela-H-Unveiling-Novel-Urease-Inhibitors-for-Helicobacter-pylori-A-MultiMethodological-Approach-from-Virtual-Screening-and-ADME-to-Molecular-Dynamics-Simulations.pdf
Tamaño:
2.55 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
Fac.CV - Artículos de Revista